Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts

Lotus Pharmaceutical

Market Cap: NT$57.3b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Oneness Biotech

Market Cap: NT$30.9b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

TaiMed Biologics

Market Cap: NT$22.9b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

EirGenix

Market Cap: NT$19.5b

Operates as a contract development and manufacturing company in Taiwan and internationally.

Medigen Vaccine Biologics

Market Cap: NT$14.2b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

Handa Pharmaceuticals

Market Cap: NT$13.1b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.

Foresee Pharmaceuticals

Market Cap: NT$11.4b

Operates as biopharmaceutical company in the United States, China, and Europe.

Formosa Laboratories

Market Cap: NT$8.1b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

SCI Pharmtech

Market Cap: NT$7.1b

Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.

TCM Biotech International

Market Cap: NT$4.1b

A biotech company, engages in the research and development of drugs for liver diseases.